1. A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail. (1st February 2021) Authors: Elewski, B.; Brand, S.; Degenhardt, T.; Curelop, S.; Pollak, R.; Schotzinger, R.; Tavakkol, A.; Alonso‐Llamazares, Javier; Ashton, Scott J.; Bhatia, Neal; Billings, Michael; Blauvelt, Andrew; Bystol, Norman; Dodson, Brandt; Gold, Michael H.; Grande, Kimberly; Jarratt, Michael; Jones, Terry S.; Ka... Journal: British journal of dermatology Issue: Volume 184:Number 2(2021) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗